Statseal Powder Specification Cover


  • For temporary external control of bleeding from indwelling catheters and procedural sites
  • Works with any protein-rich body fluid to prevent oozing and bleeding
  • Creates a hostile barrier to microbial penetration over the site 5
  • Reduces unplanned dressing changes 4,6
  • Keeps sites dry and intact until scheduled dressing change 4,6,7
  • Reduces risk of infection, nursing time and material cost 3,4,6,7
  • Improves delivery of atraumatic care and patient comfort 6
  • Applications from PICC/CVC placement, dialysis or arterial catheters, ECMO cannulas or hemodynamic support devices to name a few
  • Easy pour tubes provide pouring accuracy

Product codes

LP636StatSeal ® Powder – case of 24 applications

How it works

StatSeal ® products are comprised of a hydrophilic polymer and potassium ferrate. As a manual pressure adjunct, StatSeal’s mechanism of action is two-step and occurs simultaneously to instantly form a low pH seal or physical barrier over the site, letting nothing in our out.
The hydrophilic polymer rapidly dehydrates the blood and absorbs exudate, stacking up blood solids beneath to form a seal.
The potassium ferrate agglomerates the blood solids and proteins together, adhering the seal to the wound to stop bleeding and oozing.
Beneath the seal, the pH is neutral, and the blood solids and proteins continue to stack naturally. Above the seal, the hydrophilic polymer exchanges protons for cations, resulting in desiccation and a pH of ~2, which creates a hostile barrier to microbial penetration. 5,6

References: [1] Timsit JF, Bouadma L, Ruckly S, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med. 2012 June;40(6):1707-14. [2] Olaechea PM, Palomar M, Alarez Lerma F, et al. Morbidity and mortality associated with primary and catheter-related blood stream infections in critically ill patients. Rev Esp Quimioter. 2013 Mar;26(1):21-9. [3] Olsen M, Morris M. Fresh Eyes Focused on Safety: Nurses Partner with Engineering Students to Eliminate CLABSIs in Cardiac Surgery Patients. Lecture presented at AVA Annual Meeting; October 4-7, 2019; Las Vegas, NV. [4] Wilder KA, Wall B, Haggard D, Epperson T. CLABSI Reduction Strategy: A Systematic Central Line Quality Improvement Initiative Integrating Line-Rounding Principles and a Team Approach. Adv Neonatal Care. 2016 Jun;16(3):170-7. [5] Biolife, LLC, 510(k) K080210, Section 18.3. [6] Blough L, Hinson K, Hen J. The science of a seal for PICC line management: bio seal CVC powder. J VAS Access. 2010;15(2):66-73. [7] Ayala, M. PICC Insertion Dressing Protocol for the Hematological Oncology Patient: A Comparison of Biopatch and StatSeal. Poster presented at AVA Annual Meeting; October 4-7, 2019; Las Vegas, NV. [8] Gorski LA, Hadaway L, Hagle M et al. 2016 infusion therapystandards of practice. Journal of Infusion Nursing, 39(1Suppl.),41:L